Virology Specimen Collection Market Report 2025

This Virology Specimen Collection report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The virology specimen collection market size has grown strongly in recent years. It will grow from $6.6 billion in 2024 to $6.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to disease outbreaks and pandemics, infectious disease research, public health initiatives, quality assurance and regulation, remote and home testing.

The virology specimen collection market size is expected to see strong growth in the next few years. It will grow to $8.84 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to global health preparedness, pandemic response infrastructure, surveillance and monitoring programs, government funding and grants, growing rapid diagnostic tests. Major trends in the forecast period include self-collection kits, point-of-care specimen collection, integrated specimen collection devices: digital health platforms, telemedicine and e-health.

The virology specimen collection market is experiencing growth driven by the increasing number of blood donations. The rise in blood sample collections has led to an increased need for virology specimen collection methods to examine and detect viruses present in the blood. For example, the World Health Organization reported a global collection of approximately 118.54 million blood donations in June 2023. The demand for virology specimen collection is expected to surge as the prevalence of blood donations continues to increase.

The virology specimen collection market is anticipated to witness further growth due to the escalating cases of viral diseases such as HIV/AIDS and influenza. Virology specimen collection plays a crucial role in diagnosing and treating viral diseases, contributing to accurate detection through appropriate specimen collection, transport, and processing. The Joint United Nations Programme on HIV/AIDS reported that 39 million people globally were living with HIV in 2022, emphasizing the critical role of virology specimen collection in addressing viral infections.

Technological advancements are playing a significant role in shaping the virology specimen collection market. Innovations, including automated sample isolation and real-time amplification technology, have facilitated the development of systems for detecting clinically relevant viruses. Nightingale Health PLC, a Finland-based health technology company, launched a remote blood collection kit in August 2023, allowing research participants to collect their own blood samples using a self-collection tool. This technological advancement enhances flexibility in medical research and clinical trials, overcoming logistical and geographic constraints.

Major companies in the virology specimen collection market are focusing on introducing advanced solutions like blood collection tubes to boost their market presence. Blood collection tubes, which are used to collect blood samples for laboratory testing, come with additives for clot acceleration or prevention. Streck, a US-based laboratory products developer and manufacturer, introduced RNA Complete BCT in February 2022. This blood collection tube maintains cell-free RNA concentration while limiting the release of extracellular vesicles, preserving crucial analytical objectives for up to seven days at room temperature.

In April 2024, Eurofins Scientific, a Luxembourg-based testing laboratory company, acquired Ascend Clinical LLC for an undisclosed amount. This strategic acquisition allows Eurofins to expand its diagnostic services, particularly for patients with kidney disease and those in need of transplant care. With the increasing demand for specialized healthcare solutions, this acquisition is timely. Ascend Clinical is a US-based provider of clinical testing services tailored specifically to the needs of renal patients.

Major companies operating in the virology specimen collection market include Puritan Medical Products Co. LLC, Becton Dickinson and Company, Quidel Corporation, Thermo Fisher Scientific Inc., Trinity Biotech plc, DiaSorin S.p.A., Vircell S.L., Copan Italia S.p.A., Hardy Diagnostics, Laboratory Corporation of America Holdings, ZeptoMetrix Corporation, Copan Diagnostics Inc., Bionote Inc., F. Hoffmann-La Roche Ltd, Meridian Bioscience Inc., Hologic Inc., Cepheid Inc., Bio-Rad Laboratories Inc., GenMark Diagnostics Inc., Luminex Corporation, Abbott Laboratories, BioFire Diagnostics LLC, Randox Laboratories Ltd., Savyon Diagnostics Ltd., Seegene Inc., Serosep Ltd., SolGent Co. Ltd., TECOmedical AG, Vela Diagnostics, Zybio Inc.

North America was the largest region in the virology specimen collection market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the global virology specimen collection market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the virology specimen collection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

A virology specimen refers to a blood sample obtained for the examination of potential infections. To effectively isolate viruses, specimens should ideally be collected within four days of the onset of illness, as the shedding of the virus significantly diminishes thereafter. Virus cultures are generally not suitable for specimens collected more than 7 days after the onset of illness, except for specific cases where authorized by government health authorities, hospitals, clinicians, and laboratories engaged in the diagnosis of relevant clinical samples.

The primary types of virology specimen collection tools include blood collection kits, specimen collection tubes, viral transport media, and swabs. The set of vials and reagents provided for use in collecting and transporting samples to the laboratory, where testing services are conducted, is referred to as the sample collection kit. Virology specimen collection samples encompass various types, such as blood samples, nasopharyngeal samples, throat samples, nasal samples, cervical samples, oral samples, and other manually or automated collected samples. These samples serve diagnostic and therapeutic purposes.

The virology specimen collection market research report is one of a series of new reports that provides virology specimen collection market statistics, including virology specimen collection industry global market size, regional shares, competitors with a virology specimen collection market share, detailed virology specimen collection market segments, market trends and opportunities, and any further data you may need to thrive in the virology specimen collection industry. This virology specimen collection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The virology specimen market consists of sales of conjunctiva (eye) swab, cerebral spinal fluid (csf), lesions, tissue specimens, and bone marrow. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.